Bedside to bench: betting on B cells in multiple sclerosis.
Hans
H
Link
D000911:Antibodies, Monoclonal / Q000276:immunology* / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology* / Q000473:pathology; D016032:Randomized Controlled Trials as Topic; D055502:Secondary Prevention
D000911:Antibodies, Monoclonal